Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Nov 22;83(11):1437–1442. doi: 10.1054/bjoc.2000.1485

Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma

M Benasso 1, G Sanguineti 2, M D'Amico 1, R Corvò 2, I Ricci 1, G Numico 3, D Guarneri 1, V Vitale 2, E Pallestrini 5, A Santelli 5, R Rosso 1
PMCID: PMC2363421  PMID: 11076650

Abstract

In locally advanced undifferentiated nasopharyngeal carcinoma (UNPC), concomitant chemo-radiotherapy is the only strategy that gave better results over radiation alone in a phase III trial. Adding effective chemotherapy to a concomitant chemo-radiotherapy programme may be a way to improve the results further. 30 patients with previously untreated T4 and/or N2–3 undifferentiated nasopharyngeal carcinoma were consecutively enrolled and initially treated with 3 courses of epidoxorubicin, 90 mg/m2, day 1 and cisplatin, 40 mg/m2, days 1 and 2, every 3 weeks. After a radiological and clinical response assessment patients underwent 3 courses of cisplatin, 20 mg/m2/day, days 1–4 and fluorouracil, 200 mg/m2/day, days 1–4, i.v. bolus, (weeks 1, 4, 7) alternated to 3 courses of radiation (week 2–3, 5–6, 8–9–10), with a single daily fractionation, up to 70 Gy. WHO histology was type 2 in 30% and type 3 in 70% of the patients. 57% had T4 and 77% N2–3 disease. All the patients are evaluable for toxicity and response. All but one received 3 courses of induction chemotherapy. Toxicity was mild to moderate in any case. At the end of the induction phase 10% of CRs, 83.3% of PRs and 6.7% of SD were recorded. All the patients but one had the planned number of chemotherapy courses in the alternating phase and all received the planned radiation dose. One patient out of 3 developed grade III–IV mucositis. Haematological toxicity was generally mild to moderate. At the final response evaluation 86.7% of CRs and 13.3% of PRs were observed. At a median follow-up of 31 months, 13.3% of patients had a loco-regional progression and 20% developed distant metastases. The 3-year actuarial progression-free survival and overall survival rates were 64% and 83%. Induction chemotherapy followed by alternating chemo-radiotherapy is feasible and patients' compliance optimal. This approach showed a very promising activity on locally advanced UNPC and merits to be investigated in phase III studies. © 2000 Cancer Research Campaign http://www.bjcancer.com

Keywords: nasopharyngeal carcinoma, chemo-radiotherapy, combined treatments

Full Text

The Full Text of this article is available as a PDF (60.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Sarraf M., LeBlanc M., Giri P. G., Fu K. K., Cooper J., Vuong T., Forastiere A. A., Adams G., Sakr W. A., Schuller D. E. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998 Apr;16(4):1310–1317. doi: 10.1200/JCO.1998.16.4.1310. [DOI] [PubMed] [Google Scholar]
  2. Chan A. T., Teo P. M., Leung T. W., Leung S. F., Lee W. Y., Yeo W., Choi P. H., Johnson P. J. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1995 Oct 15;33(3):569–577. doi: 10.1016/0360-3016(95)00218-N. [DOI] [PubMed] [Google Scholar]
  3. Chatani M., Teshima T., Inoue T., Azuma I., Yoshimura H., Oshitani T., Hashiba M., Nishiyama K., Tsutsui K., Fujimura T. Radiation therapy for nasopharyngeal carcinoma. Retrospective review of 105 patients based on a survey of Kansai Cancer Therapist Group. Cancer. 1986 Jun 15;57(12):2267–2271. doi: 10.1002/1097-0142(19860615)57:12<2267::aid-cncr2820571205>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  4. Chen W. Z., Zhou D. L., Luo K. S. Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC). Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):311–314. [PubMed] [Google Scholar]
  5. Chu A. M., Flynn M. B., Achino E., Mendoza E. F., Scott R. M., Jose B. Irradiation of nasopharyngeal carcinoma: correlations with treatment factors and stage. Int J Radiat Oncol Biol Phys. 1984 Dec;10(12):2241–2249. doi: 10.1016/0360-3016(84)90229-3. [DOI] [PubMed] [Google Scholar]
  6. Chua D. T., Sham J. S., Choy D., Lorvidhaya V., Sumitsawan Y., Thongprasert S., Vootiprux V., Cheirsilpa A., Azhar T., Reksodiputro A. H. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Cancer. 1998 Dec 1;83(11):2270–2283. [PubMed] [Google Scholar]
  7. Cvitkovic E., Bachouchi M., Armand J. P. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications. Hematol Oncol Clin North Am. 1991 Aug;5(4):821–838. [PubMed] [Google Scholar]
  8. Ho J. H., Chan C. L., Lau W. H., Au G. K., Koo L. C. Cancer in Hong Kong: some epidemiological observations. Natl Cancer Inst Monogr. 1982;62:47–55. [PubMed] [Google Scholar]
  9. Hoppe R. T., Goffinet D. R., Bagshaw M. A. Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy. Cancer. 1976 Jun;37(6):2605–2612. doi: 10.1002/1097-0142(197606)37:6<2605::aid-cncr2820370607>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  10. Huang S. C., Lui L. T., Lynn T. C. Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys. 1985 Oct;11(10):1789–1793. doi: 10.1016/0360-3016(85)90033-1. [DOI] [PubMed] [Google Scholar]
  11. Huang S. C. Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys. 1980 Apr;6(4):401–407. [PubMed] [Google Scholar]
  12. Kosmidis P., Mylonakis N., Skarlos D. V., Samantas E., Beer M., Theocharis D., Zachariadis E., Gioti A., Papadakis E., Poulakis N. A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials. Ann Oncol. 1994 Feb;5(2):159–162. doi: 10.1093/oxfordjournals.annonc.a058769. [DOI] [PubMed] [Google Scholar]
  13. Lee A. W., Poon Y. F., Foo W., Law S. C., Cheung F. K., Chan D. K., Tung S. Y., Thaw M., Ho J. H. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23(2):261–270. doi: 10.1016/0360-3016(92)90740-9. [DOI] [PubMed] [Google Scholar]
  14. Merlano M., Vitale V., Rosso R., Benasso M., Corvò R., Cavallari M., Sanguineti G., Bacigalupo A., Badellino F., Margarino G. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med. 1992 Oct 15;327(16):1115–1121. doi: 10.1056/NEJM199210153271602. [DOI] [PubMed] [Google Scholar]
  15. Mesic J. B., Fletcher G. H., Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys. 1981 Apr;7(4):447–453. doi: 10.1016/0360-3016(81)90129-2. [DOI] [PubMed] [Google Scholar]
  16. Qin D. X., Hu Y. H., Yan J. H., Xu G. Z., Cai W. M., Wu X. L., Cao D. X., Gu X. Z. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988 Mar 15;61(6):1117–1124. doi: 10.1002/1097-0142(19880315)61:6<1117::aid-cncr2820610611>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  17. Qin D. X., Hu Y. H., Yan J. H., Xu G. Z., Cai W. M., Wu X. L., Cao D. X., Gu X. Z. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988 Mar 15;61(6):1117–1124. doi: 10.1002/1097-0142(19880315)61:6<1117::aid-cncr2820610611>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  18. Rossi A., Molinari R., Boracchi P., Del Vecchio M., Marubini E., Nava M., Morandi L., Zucali R., Pilotti S., Grandi C. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol. 1988 Sep;6(9):1401–1410. doi: 10.1200/JCO.1988.6.9.1401. [DOI] [PubMed] [Google Scholar]
  19. Sanguineti G., Geara F. B., Garden A. S., Tucker S. L., Ang K. K., Morrison W. H., Peters L. J. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):985–996. doi: 10.1016/s0360-3016(97)00104-1. [DOI] [PubMed] [Google Scholar]
  20. Vikram B., Mishra U. B., Strong E. W., Manolatos S. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys. 1985 Aug;11(8):1455–1459. doi: 10.1016/0360-3016(85)90332-3. [DOI] [PubMed] [Google Scholar]
  21. Zhang E. P., Liang P. G., Li Z. Q., Cai G. L., Chen Y. F., Cai M. D., Zeng X. F., Guan X. X. 10-year survival of nasopharyngeal carcinoma. A report of 1,302 cases. Chin Med J (Engl) 1987 May;100(5):419–424. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES